Tofacitinib for patients with anti-TNF refractory ulcerative proctitis: a multicenter cohort study from the GETAID.
Mathieu UzzanMaria NachuryAlexandre NuzzoAurélien AmiotBénédicte CaronAlban BenezechAnthony BuissonGuillaume BouguenCatherine Le BerreCatherine ReenaersGuillaume Le CosquerGuillaume SavoyeMaeva CharkaouiMathias VidonLucas GuilloMathurin FumeryLaurent Peyrin-BirouletJulien KirchgesnerYoram Bouhniknull nullPublished in: Journal of Crohn's & colitis (2023)
Tofacitinib may offer a therapeutic option for patients with refractory UP.